Crohn's Disease and Colitis Trial, Recruiting NCT05578235 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05578235
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female and are older than 16 years of age
  • You have Crohn's disease affecting a specific part of your bowel (the area where the small and large intestine meet, or a similar area after previous surgery) that your doctors have recommended needs an operation
  • You are currently taking medications such as steroids, anti-inflammatory drugs, or other medicines used to treat bowel disease — these are still allowed
  • You have recently had a colonoscopy (camera test of the bowel) and an up-to-date scan, such as an ultrasound or MRI scan
  • You are able and willing to follow the study's requirements and attend follow-up appointments
  • You are able to understand the trial and sign a consent form agreeing to take part
  • Your case has been reviewed and discussed by a team of specialist doctors at your local hospital

Who may not be able to join:

  • You are not able to give your consent to take part in the trial
  • You are under 16 years of age
  • You have had a serious health problem in the last six months, such as a heart attack, chest pain (angina), or heart failure — or another condition that the doctors feel could put you at risk (confirm with trial site)
  • You have been diagnosed with cancer within the last 5 years that could affect your health outlook
  • You need emergency surgery right away
  • You are currently pregnant or breastfeeding
  • You are unable to attend follow-up appointments at 3, 6, and 12 months after your operation, which include check-ups, scans, and a camera test of the bowel

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: W.A. Bemelman, Prof. dr., Amsterdam UMC, location AMC

Phone: 0031650828323

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Registry
ClinicalTrials.gov
Start date
13 July 2023
Est. completion
1 October 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Postoperative endoscopic recurrence at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov